Quince Therapeutics: Cornerstone Capital Bank Celebrates Top Originators and Growth Achievements
- Cornerstone Capital Bank's loan officers excel, with over one-third recognized in Scotsman Guide's 2025 Top Originators ranking.
- The bank funds over twice the home loans compared to competitors, showcasing strong operational capabilities and client dedication.
- Cornerstone Capital Bank, formed from a merger, is Texas' highest-capitalized new bank and emphasizes a positive work culture.
Cornerstone Capital Bank Celebrates Top Originators and Commitment to Growth
Cornerstone Capital Bank, based in Houston, Texas, recently marks a significant milestone with over one-third of its residential mortgage loan officers being recognized in the Scotsman Guide 2025 Top Originators ranking. This prestigious acknowledgment highlights the exceptional performance of the bank’s loan officers, who are evaluated against a rigorous standard requiring a minimum of $25 million in annual funded loan volume or at least 75 closed loans. The recognition encompasses professionals from Cornerstone Home Lending, the bank's residential mortgage division, as well as its joint venture partnerships with builders and realty brokerages. This achievement underlines the bank's strong positioning within the competitive mortgage financing landscape.
In 2024, the loan officers at Cornerstone Capital Bank demonstrate remarkable productivity, funding over twice the number of home loans compared to their closest competitor. The bank originates more than double the annual loan volume, showcasing its robust operational capabilities and dedication to serving clients. Adam Laird, CEO of Cornerstone Home Lending, emphasizes the company's focus on empowering loan officers through strategic investments in resources and tools that foster business growth. This commitment is reflected in the positive impact the bank has on families, having provided over 21,000 home loans within the year.
Furthermore, Cornerstone Capital Bank, formed from the 2022 merger of Cornerstone Home Lending and The Roscoe State Bank, distinguishes itself as Texas' highest-capitalized new bank at the time of the merger. With a workforce of 1,500 employees, the bank serves a vast customer base, having established more than 600,000 relationships across mortgage financing, commercial financing, and deposit accounts. The bank is also celebrated as a certified Fortune Great Place to Work® and has received multiple accolades as a Top Workplace, demonstrating its commitment to fostering a positive work culture.
In addition to its impressive achievements in mortgage lending, Cornerstone Capital Bank continues to strengthen its community ties through various initiatives aimed at enhancing customer relationships. The bank's strategic approach to integrating advanced technology and personalized services positions it favorably for future growth in an ever-evolving financial landscape. The recognition of its loan officers not only elevates the bank's profile but also reinforces its dedication to excellence and service in the mortgage industry.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…